Results 171 to 180 of about 943,421 (294)

Azaporphyrinoid‐Based Photo‐ and Electroactive Architectures for Advanced Functional Materials

open access: yesAdvanced Materials, EarlyView.
A long‐standing collaboration between the Torres and Guldi groups has yielded diverse azaporphyrinoid‐based donor‐acceptor nanohybrids with promising applications in solar energy conversion. This conspectus highlights key molecular platforms and structure‐function relationships that govern light and charge management, supporting the rational design of ...
Jorge Labella   +3 more
wiley   +1 more source

Posterior Malleolus Fixation in Trimalleolar Ankle Fractures: Outcomes From a Single-Centre Retrospective Cohort. [PDF]

open access: yesCureus
Shah S   +9 more
europepmc   +1 more source

High Charge Carrier Mobility in Non‐Conjugated 3D Covalent Organic Frameworks

open access: yesAdvanced Materials, EarlyView.
A non‐conjugated 3D COF constructed via boronate ester linkages from tetraphenylene and pyrene‐based monomers is reported, which exhibits a high charge carrier mobility of 14 ± 1 cm2 V−1 s−1. ABSTRACT π‐Conjugation, π–π stacking, and long‐range order play a central role in determining charge transport efficiency in organic materials.
Joaquín Almarza   +11 more
wiley   +1 more source

Machine Learning–Assisted Bio‐Interfacial Engineering Resolves Structural–Functional Conflicts in Nanocomposites

open access: yesAdvanced Materials, EarlyView.
A machine learning‐guided bio‐interfacial design strategy resolves the long‐standing strength–toughness–functionality trade‐off in nanocomposites. By efficiently mapping high‐performance regions in the composition–processing space, the approach delivers hierarchically entangled, nanosheet‐pinned architectures that combine mechanical robustness ...
Hao Wang   +10 more
wiley   +1 more source

Ultrasound‐Responsive Dual‐Prodrug Nanoassembly for “Fenestrae‐Restoration Strategy” in Liver Fibrosis Therapy

open access: yesAdvanced Materials, EarlyView.
ABSTRACT Liver fibrosis is a serious yet reversible intermediate stage in the progression of liver disease, which can ultimately advance to cirrhosis and hepatocellular carcinoma. Targeted and selective inhibition of activated hepatic stellate cells (aHSCs) has emerged as a promising therapeutic strategy for the treatment of liver fibrosis.
Shutong Liu   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy